Long term, tamoxifen stops more cancer than Evista
Longer-term results from a head-to-head trial of two drugs that prevent breast cancer shows that tamoxifen works better than rival Eli Lilly and Co’s Evista, but with a greater risk of some other cancers and blood clots.
Read more on Reuters via Yahoo! News
Studies Confirm Link Between Breast Density and Cancer
WEDNESDAY, April 21 (HealthDay News) — Having dense breasts has long been known to increase a woman’s risk for breast cancer, and new research confirms that a decline in breast density over time does, in fact, decrease that risk.
Read more on HealthDay via Yahoo! News
Sweetened beverages linked to pancreas cancer
A new study finds drinking two or more sweetened drinks per week increases one’s risk of developing pancreatic tumors — the rare but deadliest type of cancer.
Read more on Press TV